newsNov 18, 202326:09pending
Who gets the weight loss drugs when supply doesn’t meet demand?
About this episode
A revolutionary new class of drugs is transforming weight loss. But around the world, demand is skyrocketing for diabetes drugs because they also help people shed pounds. Join our global health journalists as we explore access to drugs like Wegovy and Ozempic and the transformation of the way we understand weight loss.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Get every episode summarized
Each time Reuters World News publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Reuters World News
AI market slump, UK crypto donations, US mail-in ballot fight
Reuters World News
Sep 14, 202612:44completed
AI slowdown, Trump's Houthi problem, Irish unity and the US Open
Reuters World News
Sep 13, 202612:13pending
Saudi pipeline, Trump in Ireland and Celine in Paris
Reuters World News
Sep 12, 202612:23completed
America remembers 9/11, inflation ticks up, Vance takes center stage (Updated)
Reuters World News
Sep 11, 202613:22completed